FOXO4-DRI
This synthetic D-retro-inverso peptide selectively targets senescent cells, inducing apoptosis by disrupting the FOXO4-p53 interaction, which allows p53 to trigger programmed cell death. By clearing dysfunctional cells that contribute to aging and inflammation, FOXO4-DRI promotes tissue regeneration, improves organ function, and may reduce age-related conditions like osteoarthritis and hypogonadism. Its enhanced stability and bioavailability make it a promising candidate for anti-aging therapies, with animal studies showing restored fitness, renal function, and testosterone levels
| Unit Size | 10 mg/vial |
| Unit Quantity | 1 Vial |
| Sequence | D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-Gly-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-Gly-OH 11 AcOH |
| Appearance | White Powder |
| Peptide Purity | >98.1% |
| Solubility | Soluble in water or 1% acetic acid |
The products offered on this website are furnished for in-vitro studies (Latin:in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
